Abstract
We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA
| Original language | English |
|---|---|
| Pages (from-to) | 367-370 |
| Number of pages | 4 |
| Journal | Infection |
| Volume | 39 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2011 |
Fingerprint
Keywords
- Drug resistance
- Entecavir
- Hepatitis B
- Immunocompromised
- Therapy
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Cite this
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. / Sarrecchia, C.; Svicher, V.; Volpi, A.; Salpini, R.; Ceccarelli, L.; Sordillo, P.; Bertoli, A.; Perno, C. F.; Andreoni, M.
In: Infection, Vol. 39, No. 4, 08.2011, p. 367-370.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
AU - Sarrecchia, C.
AU - Svicher, V.
AU - Volpi, A.
AU - Salpini, R.
AU - Ceccarelli, L.
AU - Sordillo, P.
AU - Bertoli, A.
AU - Perno, C. F.
AU - Andreoni, M.
PY - 2011/8
Y1 - 2011/8
N2 - We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA
AB - We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA
KW - Drug resistance
KW - Entecavir
KW - Hepatitis B
KW - Immunocompromised
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=80655144427&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80655144427&partnerID=8YFLogxK
U2 - 10.1007/s15010-011-0127-3
DO - 10.1007/s15010-011-0127-3
M3 - Article
VL - 39
SP - 367
EP - 370
JO - Infection
JF - Infection
SN - 0300-8126
IS - 4
ER -